2X69
X-ray Structure of Macrophage Inflammatory Protein-1 alpha polymer
Summary for 2X69
| Entry DOI | 10.2210/pdb2x69/pdb |
| Related | 1B50 1B53 2X6G |
| Descriptor | C-C MOTIF CHEMOKINE 3 (2 entities in total) |
| Functional Keywords | immune system, inflammatory response, cytokine, chemotaxis |
| Biological source | HOMO SAPIENS (HUMAN) |
| Cellular location | Secreted: P10147 |
| Total number of polymer chains | 5 |
| Total formula weight | 38968.32 |
| Authors | |
| Primary citation | Ren, M.,Guo, Q.,Guo, L.,Lenz, M.,Qian, F.,Koenen, R.R.,Xu, H.,Schilling, A.B.,Weber, C.,Ye, R.D.,Dinner, A.R.,Tang, W. Polymerization of Mip-1 Chemokine (Ccl3 and Ccl4) and Clearance of Mip-1 by Insulin-Degrading Enzyme. Embo J., 29:3952-, 2010 Cited by PubMed Abstract: Macrophage inflammatory protein-1 (MIP-1), MIP-1α (CCL3) and MIP-1β (CCL4) are chemokines crucial for immune responses towards infection and inflammation. Both MIP-1α and MIP-1β form high-molecular-weight aggregates. Our crystal structures reveal that MIP-1 aggregation is a polymerization process and human MIP-1α and MIP-1β form rod-shaped, double-helical polymers. Biophysical analyses and mathematical modelling show that MIP-1 reversibly forms a polydisperse distribution of rod-shaped polymers in solution. Polymerization buries receptor-binding sites of MIP-1α, thus depolymerization mutations enhance MIP-1α to arrest monocytes onto activated human endothelium. However, same depolymerization mutations render MIP-1α ineffective in mouse peritoneal cell recruitment. Mathematical modelling reveals that, for a long-range chemotaxis of MIP-1, polymerization could protect MIP-1 from proteases that selectively degrade monomeric MIP-1. Insulin-degrading enzyme (IDE) is identified as such a protease and decreased expression of IDE leads to elevated MIP-1 levels in microglial cells. Our structural and proteomic studies offer a molecular basis for selective degradation of MIP-1. The regulated MIP-1 polymerization and selective inactivation of MIP-1 monomers by IDE could aid in controlling the MIP-1 chemotactic gradient for immune surveillance. PubMed: 20959807DOI: 10.1038/EMBOJ.2010.256 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.65 Å) |
Structure validation
Download full validation report






